Immediate Impact
65 standout
Citing Papers
Chronic kidney disease
2025 Standout
GPCR drug discovery: new agents, targets and indications
2025 Standout
Works of Warren Wen being referenced
Efficacy of Difelikefalin in Subjects With Moderate-to-Severe Chronic Kidney Disease–Associated Pruritus: Pooled Subgroup Analysis of KALM-1 and KALM-2
2021
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Warren Wen | 290 | 319 | 196 | 47 | 692 | |
| Michael Butler | 39 | 204 | 132 | 50 | 760 | |
| C T Dollery | 308 | 30 | 46 | 33 | 770 | |
| F.E.R. Simons | 322 | 113 | 21 | 26 | 628 | |
| Xiaolei Huang | 46 | 45 | 78 | 52 | 692 | |
| Wei Zhang | 149 | 8 | 89 | 60 | 792 | |
| Pedram Paragomi | 89 | 15 | 92 | 55 | 836 | |
| H. E. Eliahou | 61 | 60 | 71 | 47 | 705 | |
| F. Philip‐Joet | 326 | 39 | 20 | 42 | 677 | |
| Alireza Jafari | 111 | 61 | 107 | 59 | 588 | |
| Mehmet Uyar | 265 | 23 | 49 | 64 | 676 |
All Works
Loading papers...